EP2491942

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    2.6.2009
  • :
    23.10.2013
  • :
    12000665.5
  • :
    1.6.2029
  • :
    Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases

2.6.2009
23.10.2013
  • :
    Xigen Inflammation Ltd.
  • :
    Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
  • :
    Bonny, Christophe
  • :
    Lausanne, CH
  • :
    PCT/EP2008/004341
  • :
    30.5.2008
  • :
    WO
  • :
    A61K 38/28, C07K 14/47, C07K 14/81, A61P 9/00